Aims and Scope

The Journal of Applied Biotechnology Reports (JABR) publishes papers describing experimental work relating to all fundamental issues of biotechnology including:

Cell Biology, Genetics, Microbiology, Immunology, Molecular Biology, Biochemistry, Embryology, Immunogenetics, Cell and Tissue Culture, Molecular Ecology, Genetic Engineering and Biological Engineering, Bioremediation and Biodegradation, Bioinformatics, Biotechnology Regulations, Pharmacogenomics, Gene Therapy, Plant, Animal, Microbial and Environmental Biotechnology, Nanobiotechnology, Medical Biotechnology, Biosafety, Biosecurity, Bioenergy, Biomass, Biomaterials and Biobased Chemicals and Enzymes.

Journal of Applied Biotechnology Reports promotes a special emphasis on:

  • Improvement methods in biotechnology
  • Optimization process for high production in fermentor systems
  • Protein and enzyme engineering
  • Antibody engineering and monoclonal antibody
  • Molecular farming
  • Bioremediation
  • Immobilizing methods
  • biocatalysis

In particular, Journal of Applied Biotechnology Reports welcomes submissions on specific areas:

  • Metabolic Engineering: Metabolic engineering is the practice of optimizing genetic and regulatory processes within cells to increase the cells' production of a certain substance. These processes are chemical networks that use a series of biochemical reactions and enzymes that allow cells to convert raw materials into molecules necessary for the cell’s survival. Metabolic engineering specifically seeks to mathematically model these networks, calculate a yield of useful products, and pinpoint parts of the network that constrain the production of these products. Generally, genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound.
  • Systems Biology and Bioinformatics: Overview and interplay between biological system components and their functional implications or focuses on complex interactions within biological systems (for example enzymes and metabolites in a metabolic pathway). Computational analysis of all topics mentioned below (modeling, algorithms, data deconvolution).
  • Nanobiotechnology and Biomaterials: Nanotechnology, as defined by size, is naturally very broad, including fields of science as diverse as surface science, organic chemistry, molecular biology, semiconductor physics, microfabrication, etc. The nanomaterial is a field that takes a materials science-based approach to nanotechnology that using for industrial biotechnology, drug delivery therapeutics, biochips, micro- and nanofluidics, nanosensors, and nanosystems for imaging; engineering materials for biological application, molecular imprinting, and biomimetics.
  • Medicine/ Red Biotechnology/ Stem Cells: Red biotechnology refers to the use of organisms for the improvement of medical processes. It includes the designing of organisms to manufacture pharmaceutical products like antibiotics and vaccines, the engineering of genetic cures through genomic manipulation, and its use in forensics through DNA profiling, Therapeutic cloning (somatic cell nuclear transfer), tissue engineering, xenotransplantation; DNA or RNA therapeutics (gene therapy, targeting, immunogenicity); vaccines and applied immunology (Ab engineering, T-cell therapies, therapies exploiting innate immunity, antigen delivery vectors and approaches); Viral or non-viral strategies for drug delivery.
  • Synthetic Biology: It is the design and construction of new biological devices (such as enzymes, genetic circuits, and cells or the redesign of existing biological systems) and systems for useful purposes. Synthetic biology builds on the advances in molecular, cell, and systems biology and seeks to transform biology in the same way that synthesis transformed chemistry and integrated circuit design transformed computing.
  • Mammalian Biotechnology/Genetics: Manipulating gene structure and control of gene expression; transgenic animals, knockouts, reproductive cloning, biopharmaceutical and enzyme production, transgene targeting and expression strategies. The development of mammalian cell biotechnology has led to an extensive range of commercially valuable prophylactic, diagnostic, and therapeutic compounds which can now be produced routinely by cell culture.
  • Industrial Biotechnology: It is the application of biotechnology for industrial purposes, including manufacturing, alternative energy as bioenergy, and biomaterials. It includes the practice of using cells or components of cells like enzymes to generate industrially useful products by yeast or other organisms, use of enzymes as industrial catalysts, biopharmaceutics, biofuels.
  • Plant Biotechnology: Crop improvement (resistance to stress, disease, pests), nutraceuticals, forest biotech, plant vaccines or bioreactors, biosecurity and gene-containment strategies, bioenergy, microbial biodegradation, food biotech, environmental biotech: bioremediation, biomining, phytoremediation, monitoring.
  • Food Biotechnology: Application of microbiology and metabolic aspects to food and beverage systems; food safety and pathogens, food fermentation, food bioactive compounds.
  • Methods: Technical aspects and practical protocols for all biotech applications; Expression systems in mammalian, insect, bacterial, fungal or plant cells; Screening methods; Novel organism/cell/molecular imaging techniques, high throughput imaging tools for drug screening, fluorescence microscopy, electron microscopy/tomography, confocal imaging ...